# Topiramate

## Trokendi XR 50mg

| TAH Drug Code      | [OTRO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OTRO)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Monotherapy for partial onset seizure in adults and children over 6 years of age. Adjuvant therapy of partial epilepsy in adults and children over 6 years old with LENNOX-GASTAUT syndrome, or primary generalized tonic-clonic epilepsy. Prevention of migraine in patients over 12 years old.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Dosing             | Partial seizure or primary generalized tonic-clonic seizure, Initial monotherapy: 10 years older: First week, 50 mg orally once daily; second week, 100 mg once daily; third week, 150 mg once daily; fourth week, 200 mg once daily; fifth week, 300 mg once daily; sixth week and thereafter, 400 mg once daily. 6-10 years old: Initial, 25 to 50 mg orally once daily; may increase by 25 to 50 mg/day at 1-week intervals to usual maintenance dose of 200 to 400 mg/day. Minimum and maximum maintenance dose: 11kg or less: 150-250 mg/day; 12-22kg: 200-300 mg/day; 23-31kg: 200-350 mg/day; 32-38kg: 250-350 mg/day; up to 38kg: 250-400 mg/day. Partial seizure, primary generalized tonic-clonic seizure or Lennox-Gastaut syndrome, Adjunct: 6 to 16 years: Initial, 25 mg orally (1 to 3 mg/kg/day) once daily at nighttime for 1 week; increase by 1 to 3 mg/kg/day at 1- to 2-week intervals to achieve optimal response; maintenance, 5 to 9 mg/kg/day. 17 years or older: Initial, 25 to 50 mg orally once daily; may increase by 25 to 50 mg/day at 1-week intervals to usual maintenance dose of 200 to 400 mg/day. Migraine prophylaxis: 12 years or older: Initial, 25 mg orally once daily at nighttime for 1 week; titration, increase by 25 mg/day in weekly intervals to 100 mg/day, longer titration intervals may be used; dosage and titration rate should be based on clinical outcome. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Recent alcohol use within 6 hours prior to or 6 hours after topiramate use. Metabolic acidosis with concomitant metformin use.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | Common Dermatologic: Flushing (Pediatric, 5% ) Endocrine metabolic: Serum bicarbonate level abnormal (25% to 67% ) Gastrointestinal: Loss of appetite (10% to 24% ), Weight decreased (4% to 21% ) Immunologic: Infectious disease (2% to 8% ) Neurologic: Confusion (3% to 11% ), Dizziness (4% to 25% ), Impaired cognition (2% to 7% ), Impaired psychomotor performance (2% to 13%), Memory impairment (3% to 12% ), Paresthesia (1% to 51% ), Reduced concentration span (2% to 10% ), Somnolence (6% to 29% ) Psychiatric: Feeling nervous (4% to 16% ), Mood disorder (4% to 11% ) Other: Fatigue (6% to 16% ), Fever (1% to 12% ) Serious Dermatologic: Erythema multiforme, Stevens-Johnson syndrome, Toxic epidermal necrolysis Endocrine metabolic: Hyperammonemia (Adolescent, 26% ), Hypohidrosis, Increased body temperature, Metabolic acidosis (Adult, 14% to 44%; pediatric, 9% to 77% ) Hepatic: Liver failure Neurologic: Drug-induced encephalopathy Ophthalmic: Angle-closure glaucoma, Glaucoma, Myopia, Visual field defect (Epilepsy, 0.1% to 1% ) Psychiatric: Suicidal thoughts Renal: Nephrolithiasis (Adult, 1% to 3% ) Other: Withdrawal symptom                                                                                                                                                                                                                                        |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| More Info          | [UpToDate](https://www.uptodate.com/contents/topiramate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

